An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Melanoma
Latest Information Update: 14 Jun 2016
Price :
$35 *
At a glance
- Drugs SBP 002 (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Freedom Eye
- 16 Nov 2006 New trial record.